Surgical treatment of obesity: Impact on diabetes and other comorbidities

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 1, 2008, Pages 1-6

  Pontiroli, Antonio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADIPOSE TISSUE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; EDITORIAL; ENERGY METABOLISM; HUMAN; METABOLISM; METHODOLOGY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; BARIATRIC SURGERY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; OBESITY; PATIENT COMPLIANCE; PATIENT SELECTION; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 37449011773     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.12.004     Document Type: Editorial

References (82)

1. Pontiroli A.E., and Galli L. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia. Acta Diabetol 35 (1998) 130-136
2. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath C.W. Body-mass index and mortality in a prospective cohort of U.S. adults. New Engl J Med 341 (1999) 1097-1105
3. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., and Bonneux L. NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138 (2003) 24-32
4. Laakso M., Edelman S.V., and Brechtel G. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest 85 (1990) 1844-1852
5. Grundy S.M. Small LDL, atherogenic dyslipidemia, and metabolic syndrome. Circulation 95 (1997) 1-4
6. Festa A., D'Agostino Jr. R., Howard G., Mykkänen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
7. Ziccardi P., Nappo F., Giugliano G., Esposito K., Marfella R., Cioffi M., et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105 (2002) 804-809
8. Steinberg H.O., Chaker H., and Leaming R.L. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
9. Arcaro G., Zamboni M., and Rossi L. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 23 (1999) 936-942
10. Luyckx F.H., Desaive C., Thiry A., Dewe W., Scheen A.J., Gielen J.E., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Dis 22 (1998) 222-226
11. Perkiomaki J.S., Koistinen M.J., and Yli Mayry S. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 26 (1995) 174-179
12. Leonardo F., Fragasso G., and Rosano G.M.C. Effect of atenolol on QT interval and dispersion in patients with syndrome X. Am J Cardiol 80 (1997) 789-790
13. Alvarez G.E., Beske S.D., Ballard T.P., and Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 106 (2002) 2533-2536
14. Festa A., D'Agostino R., Hales C.N., Mykkanen L., and Haffner S.M. HR in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 23 (2000) 624-628
15. Kaaja R.J., and Poyhonen-Alho M.K. Insulin resistance and sympathetic overactivity in women. J Hypertens 24 (2006) 131-141
16. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Abedini S., and Hansen J.F. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 25 (2004) 363-370
17. Natali A., Toschi E., Baldeweg S., Ciociaro D., Favilla S., Sacca L., et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 55 (2006) 1133-1140
18. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
19. Cottam D.R., Mattar S.G., Barinas-Mitchell E., Eid G., Kuller L., Kelley D.E., et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14 (2004) 589-600
20. Moreno P.R., and Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol 44 (2004) 2293-2300
21. McGill Jr. H.C., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105 (2002) 2712-2718
22. Hall J.E., Hildebrandt D.A., and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14 (2001) 103S-115S
23. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
24. Pontiroli A.E., Pizzocri P., and Folli F. Plasma leptin levels and coronary heart disease. Circulation 106 (2002) e42
25. Wadden T.A. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 119 (1993) 688-693
26. Brown S.A., Upchurch S., Anding R., Winter M., and Ramirez G. Promoting weight loss in type II diabetes. Diabetes Care 19 (1996) 613-624
27. North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults (2000), National Institutes of Health, Bethesda, MD [NIH publication 00-4084]
28. Wadden T.A., Butryn M.L., and Byrne K.J. Efficacy of lifestyle modification for long-term weight control. Obes Res 12 Suppl. (2004) 151S-162S
29. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
30. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 163 (2003) 2146-2148
31. Sauerland S., Angrisani L., Belachew M., Chevallier J.M., Favretti F., Finer N., et al. European Association for Endoscopic Surgery. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 19 (2005) 200-221
32. NIH Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med 115 (1991) 956-961
33. Pontiroli A.E., Pizzocri P., Librenti M.C., Vedani P., Marchi M., Cucchi E., et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87 (2002) 3555-3561
34. Ito H., Ohshima A., Inoue M., Ohto N., Nakasuga K., Kaji Y., et al. Weight reduction decreases soluble cellular adhesion molecules in obese women. Clin Exp Pharmacol Physiol 29 (2002) 399-404
35. Pontiroli A.E., Pizzocri P., Koprivec D., Vedani P., Marchi M., Arcelloni C., et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 1 50 (2004) 195-200
36. Pontiroli A.E., Pizzocri P., Saibene A., Girola A., Koprivec D., and Fragasso G. Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. Int J Obes Relat Metab Disord 28 (2004) 1118-1123
37. Veronelli A., Laneri M., Ranieri R., Koprivec D., Vardaro D., Paganelli M., et al. White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care 27 (2004) 2501-2502
38. Uzun H., Zengin K., Taskin M., Aydin S., Simsek G., and Dariyerli N. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg 14 (2004) 659-665
39. Adami G.F., Cordera R., Camerini G., Marinari G.M., and Scopinaro N. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 28 (2004) 671-673
40. Pontiroli A.E., Pizzocri P., Paroni R., and Folli F. Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in Grade III (WHO) obesity. Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding (LAGB). Diabetes Care 29 (2006) 2735-2738
41. Kuzmak L.I. Invited commentary: Swedish adjustable gastric banding. Obes Surg 7 (1997) 206
42. Gomez C.A. Gastroplasty in morbid obesity. Surg Clin North Am 59 (1979) 1113-1120
43. Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-352
44. Doldi S.B., Lattuada E., Zappa M.A., Pieri G., Restelli A., and Micheletto G. Biliointestinal bypass: another surgical option. Obes Surg 8 (1998) 566-569
45. Scopinaro N., Adami G.F., Marinari G.M., Gianetta E., Traverso E., Friedman D., et al. Biliopancreatic diversion. World J Surg 22 (1998) 936-946
46. Genco A., Bruni T., Doldi S.B., Forestieri P., Marino M., Busetto L., et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obes Surg 15 (2005) 1161-1164
47. Herve J., Wahlen C.H., Schaeken A., Dallemagne B., Dewandre J.M., Markiewicz S., et al. What becomes of patients one year after the intragastric balloon has been removed?. Obes Surg 15 (2005) 864-870
48. Chapman A.E., Kiroff G., Game P., Foster B., O'Brien P., Ham J., et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135 (2004) 326-351
49. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
50. Flum D.R., Salem L., Elrod J.A., Dellinger E.P., Cheadle A., and Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 294 (2005) 1903-1908
51. Zingmond D.S., McGory M.L., and Ko C.Y. Hospitalization before and after gastric bypass surgery. JAMA 294 (2005) 1918-1924
52. Ballare M., Orsello M., and Del Piano M. A case of death after insertion of an intragastric balloon for treatment of morbid obesity. Dig Liver Dis 36 (2004) 499
53. Long S.D., O'Brien K., MacDonald Jr. K.G., Leggett-Frazier N., Swanson M.S., Pories W.J., et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17 (1994) 372-375
54. Sjostrom L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
55. Pontiroli A.E., Folli F., Paganelli M., Micheletto G., Pizzocri P., Vedani P., et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 28 (2005) 2703-2709
56. MacDonald Jr. K.G., Long S.D., Swanson M.S., Brown B.M., Morris P., Dohm G.L., et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
57. Christou N.V., Sampalis J.S., Liberman M., Look D., Auger S., McLean A.P., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-423
58. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
59. Himeno E., Nishino K., Nakashima Y., Kuroiwa A., and Ikeda M. Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 131 (1996) 313-319
60. Karason K., Wallentin I., Larsson B., and Sjostrom L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. Br Med J (Clin Res Ed) 315 (1997) 912-916
61. Tajmir P., Ceddia R.B., Li R.K., Coe I.R., and Sweeney G. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 145 (2004) 1550-1555
62. Perego L., Pizzocri P., Corradi D., Maisano F., Paganelli M., Fiorina P., et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab 90 (2005) 4087-4093
63. Vansant G., Van Gaal L., Van Acker K., and De Leeuw I. Short and long term effects of a very low calorie diet on resting metabolic rate and body composition. Int J Obes 13 Suppl. 2 (1989) 87-89
64. Kreitzman S.N., Coxon A.Y., Johnson P.G., and Ryde S.J. Dependence of weight loss during very low calorie diets on total energy expenditure rather than on resting metabolic rate which is associated with fat free mass. Am J Clin Nutr 56 Suppl. 1 (1992) 258S-261S
65. Tacchino R.M., Mancini A., Perrelli M., Bianchi A., Gianmpietro A., and Miliardi D. Body composition and energy expenditure: relationship and changes in obese subjects before and after biliopancreatic diversion. Metabolism 52 (2003) 552-558
66. Dass S.K., Roberts S.B., McCrory M.A., Hsu L.K., Shikora S.A., and Kehayias J.J. Long term changes in energy expenditure and body composition after massive weight loss induced by gastric by-pass surgery. AM J Clin Nutr 78 (2003) 22-30
67. Guida B., Belfiore A., Angrisani L., Micanti F., Mauriello C., Trio R., et al. Laparoscopic gastric banding and body composition in morbid obesity. Nutr Metab Cardiovasc Dis 15 (2005) 198-203
68. Scavini M., Pontiroli A.E., and Folli F. Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. N Engl J Med 353 (2006) 2822-2823
69. Muscelli E., Mingrone G., Camastra S., Manco M., Pereira J.A., Pareja J.C., et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 118 (2005) 51-57
70. Guidone C., Manco M., Valera-Mora E., Iaconelli A., Gniuli D., Mari A., et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55 (2006) 2025-2031
71. Briatore L., Adami G.F., Salani B., Andraghetti G., Maggi D., Danovano C., et al. La DBP migliora a breve termine la risposta insulinica precoce in soggetti obesi con diabete mellito. Il Diabete 18 Suppl. 1 (2006) 54 [abstract]
72. Weiner R., Datz M., Wagner D., and Bockhorn H. Quality-of-life outcome after laparoscopic adjustable gastric banding for morbid obesity. Obes Surg 9 6 (1999) 539-545
73. Dixon J.B., Dixon M.E., and O'Brien P.E. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 9 (2001) 713-721
74. Dixon J.B., and O'Brien P.E. Selecting the optimal patient for LAP-BAND placement. Am J Surg 184 (2002) 17S-20S
75. Branson R., Potoczna N., Brunotte R., Piec G., Ricklin T., Steffen R., et al. Impact of age, sex and body mass index on outcomes at four years after gastric banding. Obes Surg 15 (2005) 834-842
76. Ray E.C., Nickels M.W., Sayeed S., and Sax H.C. Predicting success after gastric bypass: the role of psychosocial and behavioral factors. Surgery 134 (2003) 555-563
77. Libeton M., Dixon J.B., Laurie C., and O'Brien P.E. Patient motivation for bariatric surgery: characteristics and impact on outcomes. Obes Surg 14 (2004) 392-398
78. Black D.W., Goldstein R.B., and Mason E.E. Psychiatric diagnosis and weight loss following gastric surgery for obesity. Obes Surg 13 (2003) 746-751
79. van Hout G.C., Verschure S.K., and van Heck G.L. Psychosocial predictors of success following bariatric surgery. Obes Surg 15 (2005) 552-560
80. Burgmer R., Grigutsch K., Zipfel S., Wolf A.M., de Zwaan M., Husemann B., et al. The influence of eating behavior and eating pathology on weight loss after gastric restriction operations. Obes Surg 15 (2005) 684-691
81. Elkins G., Whitfield P., Marcus J., Symmonds R., Rodriguez J., and Cook T. Noncompliance with behavioral recommendations following bariatric surgery. Obes Surg 15 (2005) 546-551
82. O'Brien P.E., Dixon J.B., Laurie C., Skinner S., Proietto J., McNeil J., et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 144 (2006) 625-633